Abstract
The aggressive form of Mantle cell non-hodgkin B cell lymphoma (MCL) has a dismal prognosis. Dual targeting BTK and BCL2 with ibrutinib and venetoclax has improved outcomes in MCL patients who were predicted not to respond to conventional therapy, but it is unlikely to be curative. Chimeric antigen receptor-modified T (CAR T) cells exhibit very effective function in elimination of relapsed/refractory B-cell lymphoid malignancies, we investigated their use in a patient with relapsed MCL. Here, we report a case of a refractory MCL in a patient who had relapsed after conventional chemotherapy and autologous CAR T cell therapy. The patient received multiple molecularly targeted therapies, including targeting BTK and BCL2, and haplo-identical CAR T (haplo-CAR T) cells from her daughter without previous allo-hematopoietic stem cell transplantation. Haplo-CAR T cells could effectively proliferate in vivo and had a clinically significant antitumor activity without serious side effects. The patient achieved a partial remission, with minimal residual disease. This case suggests that haplo-CAR T cell therapy can be effective in controlling lymphoma that failed to respond to autologous CAR T cell therapy and overcome limitation of autologo...Continue Reading
References
Oct 31, 2002·Nature Immunology·Gavin P DunnRobert D Schreiber
Nov 26, 2008·Blood·Hans-Jochem Kolb
Dec 14, 2011·Blood·James N KochenderferSteven A Rosenberg
Jun 22, 2013·Cancer Gene Therapy·H KarlssonS I A Loskog
Apr 2, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Fabiola Cervantes-GomezVarsha Gandhi
Aug 1, 2015·Human Gene Therapy·Gunilla EnbladAngelica S I Loskog
Sep 22, 2015·Current Opinion in Hematology·Yinmeng YangTerry J Fry
Jan 28, 2016·Blood·Joseph A FraiettaMarcela V Maus
Jan 29, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marco RuellaMariusz A Wasik
Apr 14, 2016·Blood·Mary Ann AndersonAndrew W Roberts
May 20, 2016·Cancer Immunology Research·Gregory A RufenerBrian G Till
Jan 18, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthew S DavidsJohn F Gerecitano
Jan 28, 2017·Molecular Therapy : the Journal of the American Society of Gene Therapy·Frederick L LockeWilliam Y Go
Mar 16, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James N KochenderferSteven A Rosenberg
Mar 29, 2018·The New England Journal of Medicine·Constantine S TamAndrew W Roberts
May 2, 2018·Nature Medicine·Joseph A FraiettaJ Joseph Melenhorst
Sep 14, 2018·Blood·Haiying QinTerry J Fry
Citations
May 3, 2019·AJNR. American Journal of Neuroradiology·H A ValandR K Tu
May 11, 2019·Clinical & Translational Immunology·Sherly MardianaPhillip Kevin Darcy
Jun 21, 2019·Current Hematologic Malignancy Reports·James N Gerson, Stefan K Barta
Dec 12, 2019·Frontiers in Oncology·Jiali ChengJianfeng Zhou
Jul 1, 2020·Terapevticheskiĭ arkhiv·V I VorobyevS K Kravchenko
Dec 19, 2019·Frontiers in Oncology·Sun YaoZhang Bin
Jan 19, 2021·Cancer Immunology, Immunotherapy : CII·Xiaoxi ZhouJianfeng Zhou
Nov 5, 2021·Expert Review of Anticancer Therapy·Lidia GattoAlba Ariela Brandes